Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +105.6% | -187.6% | 2 / 3 | +78.0% | -1.08 pp | +0.37 pp | +12.5% | 0.37 | 13.86 | 136.218 | +78,0% | 3.045 | +113,8% | 13.86 | 19.27 | −28,1% |
| Pts | 12 | 0 | 8 | 12 | 4 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 35.150 (close price on 2026-10-19)EPS (TTM): 2.535
Financial charts
1.Revenue & growth
VND bn136.218Q2/26
1.Revenue & growth
VND bn136.218Q2/26
2.Profit & growth
VND bn2.809Q2/26
3.Profit mix (Penman)
VND bn4.507Q2/26
4.Margins & cost structure
%5.2%Q2/26
5.Returns & cash cycle
% · days15.0%Q2/26
6.Earnings quality & cash
VND bn5.571Q2/26
7.Asset structure
VND bn87.876Q2/26
8.Funding & debt health
VND bn · times87.876Q2/26
9.Revenue backlog
VND bn515Q2/26
10.Valuation
times · %13,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.171Q2/26
Adjusted EPS growth, latest quarter
106%
Average adjusted EPS growth, 3 quarters
-188%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26